Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc. V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.
The Cannabis Report: June 24, 2022
Nextleaf to launch THC-O as an excise tax-free alternative to Delta-9-THC Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate,... read article.

XORTX Now Following IM Cannabis' Evil Path

XORTX Therapuetics was a company with great promise and now they face the same fate as IM Cannabis in becoming IM Delisted.  rate and reply
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.

New Press Release - XORTX Announces "Fireside Chat" with XORTX CEO

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce...read article.

RE:RE:After good news there is bad one

Why do u worry when everyone is losing on todays markets. Bitcoin. Gold and on and on and on. SORRY WELCOME TO THE REAL WORLD.  rate and reply

New Press Release - XORTX to Present at BIO International Convention 2022

CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce...read article.

RE:After good news there is bad one

You are dead on!!! These mf's are fooling the investors  rate and reply

Depressing Share Price

How many more investors can afford to lose, like the ones that saw XORTEX rolled back at $10.00 and now down to $1.00. Really sickening!! Stockhouse Logo Search Companies, etc News Press Releases...read more

After good news there is bad one

Is travels are tooo expensive, get davidof to work and show the work not travel to see investors . Are you looking for financing and dilution you mf   rate and reply

New Press Release - XORTX to Present at LD Micro Invitational 2022

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce...read article.

Xrtx on Nasdaq is up 16% now

Tsx on canafian side  has lower volume and only 6% wow you cCsnadians   rate and reply

RE:On Nasdaq is 10% already

Converted Nasdaq price to Canadian dollar it trades at $2.12 Canadian   rate and reply

On Nasdaq is 10% already

Let's see $2 next trade on Canadian side ,   rate and reply

Price crossed 21 day moving average

This one is $5 back in a week   rate and reply

On Nasdaq is up 7% , tsx trades down 2.5%

Something has to give, I go with Nasdaq trades and like it   rate and reply

Starting run , today again 30-30% up?

At Nasdaq is up 9% already.   rate and reply

9% up on Nasdaq already

Starting to go up   rate and reply

RE:RE:RE:RE:This news should have 50% gain

Look at Nasdaq is up 9% already this morning,   rate and reply

RE:Strong BUY initiated, now 1.80 target $17.50

It's a BS lie without a link. Alliance has a $11 cdn tp. https://europac.bluematrix.com/sellside/EmailDocViewer?encrypt=3d118b2d-89c3-40dc-b38e-8ba0270761f3&mime=pdf&co=Europac&id...read more

RE:RE:RE:This news should have 50% gain

All shareholders were expecting this addition to the company . Now news on USA drug approval and this is going well into target . $17.50 USA   rate and reply

RE:Strong BUY initiated, now 1.80 target $17.50

Strong BUY initiated, now 1.80 target $17.50 XRTX Analyst Research XRTX Analyst Ratings CONSENSUSStrong Buy target price $17.50 USD   rate and reply

With yo days news is s value stock

Target $17.50 USA   rate and reply
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >